The risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Anissa Boumlic
Advertisement
Anissa Boumlic, PHD, is associate director EMEA vaccine and viral therapies, MilliporeSigma.
Articles by Anissa Boumlic
Advertisement
Latest Updated Articles
Preventing Microbial Contamination of Viral Vaccines and VectorsPublished: October 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
